Skip to main content

Animations

MJFF Publications

3921 - 3930 of 8825 Results
Title
Year
  • Year
  • 2011
  • 2015
  • 2011
  • 2013
  • 2011
  • 2009
  • 2012
  • 2011
  • 2011
  • 2015
  • Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    2011
    Summary Details
    OPEN
    Title: Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    Journal Name: Narrative Inquiry in Bioethics
    Publisher: Project MUSE
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1353/nib.2011.0046
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-015-1395-2
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Models for LRRK2-Linked Parkinsonism
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.4061/2011/942412
    Citation Count: 35
  • Summary Details
    OPEN
    Title: Atypical presentation of late‐onset Tay‐sachs disease
    Journal Name: Muscle & Nerve
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mus.24146
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e31820ee1bb
    Citation Count: 17
  • Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa
    2009
    Summary Details
    RESTRICTED
    Title: Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2009.11.066
    Citation Count: 25
  • Summary Details
    OPEN
    Title: The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson’s Alpha Synuclein Expression
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/142372
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Sleep Duration and “on” Time during Different Periods of the Day and Night in Patients with Advanced Parkinson's Disease Receiving Adjunctive Ropinirole Prolonged Release
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.4061/2011/354760
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.4061/2011/659694
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom5031210
    Citation Count: 13
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.